Core Scientific, Inc./tx
Close on Oct 19, 2026
- Market cap
- $4.47B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Oct 23, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 28, 2026 | Before market open | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | After market close | $115.20M | $-1.06 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 2, 2026 | After market close | $79.80M | $0.42 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 24, 2025 | After market close | $81.10M | $-0.46 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 8, 2025 | After market close | $78.60M | $-0.04 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 7, 2025 | After market close | $79.50M | $1.25 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 26, 2025 | After market close | $94.90M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | After market close | $95.40M | $-1.17 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 8, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 12, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on May 7, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| annualized colocation revenue | entering 2026 | $360.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Core Scientific filed with the SEC
EX-99.1 to Form 8-K
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Second Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Second Quarter 2026 Earnings Call July 28, 2026 1
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
[email protected] AMD Contact: Brandi Martina AMD Communications (512) 705-1720 [email protected] Liz Stine AMD Investor Relations (720) 652-3965 [email protected]
Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Second Quarter 2026 Earnings Call July 28, 2026 1
Unregistered share sale · Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces First Quarter Fiscal Year 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter Fiscal 2026 Earnings Call May 6, 2026 1
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Core Scientific Announces Pricing of $3.3 Billion of Senior Secured Notes
Material agreement · Agreement terminated · New financial obligation · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
-end- reliance on these forward-looking statements, which speak only as of the date they are made. Please follow us on: https://www.linkedin.com/company/corescientific/ https://twitter.com/core_scientific https://www.youtube.com/@Core_Scientific Investors: [email protected] Media: press@cores…
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Proposed Offering of $3.3 Billion of Senior Secured Notes
Regulation FD disclosure · EX-99.1 to Form 8-K
Supplemental Information regarding Core Scientific, Inc., dated April 21, 2026
Regulation FD disclosure · EX-99.2 to Form 8-K
-end- Investors: [email protected] Media: [email protected]
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results
Results of operations · Prior financials no longer reliable · Regulation FD disclosure · EX-99.1 to Form 8-K
Fourth Quarter Fiscal 2025 Earnings Call March 2, 2026 1
Results of operations · Prior financials no longer reliable · Regulation FD disclosure · EX-99.2 to Form 8-K
Adam Sullivan, CEO Jim Nygaard, CFO Matt Brown, COO October 30, 2025 Investor
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Termination of Merger Agreement with CoreWeave
Agreement terminated · Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Preliminary Results of Special Meeting of Stockholders
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Fiscal Third Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Proposed Merger between Core Scientific and CoreWeave October 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Proposed Merger between Core Scientific and CoreWeave October 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Fiscal Second Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CoreWeave to Acquire Core Scientific
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Departure of Board Member Todd Becker
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Appoints Elizabeth Crain to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Core Scientific Announces Fiscal First Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter 2025 Earnings Presentation Adam Sullivan, CEO Jim Nygaard, CFO Matt Brown, COO May 7, 2025
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
March 2025 Production and Operations Updates
Regulation FD disclosure · EX-99.1 to Form 8-K
[email protected] Source: Core Scientific, Inc.
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Planned CFO Transition
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific and CoreWeave Announce $1.2 Billion Expansion at Denton, TX Site
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Fiscal Fourth Quarter and Full Fiscal Year 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Fourth Quarter Fiscal 2024 Earnings Presentation Adam Sullivan, CEO Denise Sterling, CFO February 26, 2025
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
January 2025 Production and Operations Updates
Regulation FD disclosure · EX-99.1 to Form 8-K
December 2024 Production and Operations Updates
Regulation FD disclosure · EX-99.1 to Form 8-K
Core Scientific Announces Proposed Convertible Senior Notes Offering
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K